Immune pathways in etiology, acute phase, and chronic sequelae of ischemic stroke

M Endres, MA Moro, CH Nolte, C Dames… - Circulation …, 2022 - Am Heart Assoc
Inflammation and immune mechanisms are crucially involved in the pathophysiology of the
development, acute damage cascades, and chronic course after ischemic stroke …

Prevalence and impact of atrial fibrillation in hospitalized patients with COVID-19: a systematic review and meta-analysis

GF Romiti, B Corica, GYH Lip, M Proietti - Journal of clinical medicine, 2021 - mdpi.com
Background: In patients with COVID-19, cardiovascular complications are common and
associated with poor prognosis. Among these, an association between atrial fibrillation (AF) …

Optical coherence tomography angiography features in post-COVID-19 pneumonia patients: a pilot study

G Cennamo, M Reibaldi, D Montorio, L D'Andrea… - American Journal of …, 2021 - Elsevier
Purpose This study investigated changes in retinal vessel density in macular and papillary
regions in post-SARS-CoV-2 pneumonia patients by means of optical coherence …

[HTML][HTML] Sulodexide in the treatment of patients with early stages of COVID-19: a randomized controlled trial

AJ Gonzalez-Ochoa, JD Raffetto… - Thrombosis and …, 2021 - thieme-connect.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may induce several
vascular endothelial-dependent systemic complications, and sulodexide has pleiotropic …

SARS-CoV-2 vaccine and thrombosis: an expert consensus on vaccine-induced immune thrombotic thrombocytopenia

I Elalamy, G Gerotziafas, S Alamowitch… - Thrombosis and …, 2021 - thieme-connect.com
Historically, the vaccination strategies developed in the second half of the 20th century have
facilitated the eradication of infectious diseases. From the onset of COVID-19 pandemic to …

N-acetylcysteine as adjuvant therapy for COVID-19–a perspective on the current state of the evidence

KK Wong, SWH Lee, KP Kua - Journal of inflammation research, 2021 - Taylor & Francis
The looming severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a
long-lasting pandemic of coronavirus disease 2019 (COVID-19) around the globe with …

The effect of statins on clinical outcome among hospitalized patients with COVID-19: a multi-centric cohort study

S Umakanthan, S Senthil, S John… - Frontiers in …, 2022 - frontiersin.org
The coronavirus disease-2019 (COVID-19) is caused by SARS-CoV-2, leading to acute
respiratory distress syndrome (ARDS), thrombotic complications, and myocardial injury …

COVID-19-associated pulmonary embolism: review of the pathophysiology, epidemiology, prevention, diagnosis, and treatment

L Ortega-Paz, AH Talasaz… - … in thrombosis and …, 2022 - thieme-connect.com
COVID-19 is associated with endothelial activation in the setting of a potent inflammatory
reaction and a hypercoagulable state. The end result of this thromboinflammatory state is an …

COVID‐19 and ischemic stroke

D Sagris, A Papanikolaou, A Kvernland… - European journal of …, 2021 - Wiley Online Library
Since the onset of the COVID‐19 pandemic, a substantial proportion of COVID‐19 patients
had documented thrombotic complications and ischemic stroke. Several mechanisms …

The central role of fibrinolytic response in COVID-19—a hematologist's perspective

HC Kwaan, PF Lindholm - International journal of molecular sciences, 2021 - mdpi.com
The novel coronavirus disease (COVID-19) has many characteristics common to those in
two other coronavirus acute respiratory diseases, severe acute respiratory syndrome …